Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2000
06/08/2000CA2353699A1 Human plasminogen activator
06/08/2000CA2353576A1 Novel nucleic acid transferring agents, compositions containing them and uses
06/08/2000CA2353563A1 Development of novel anti-microbial agents based on bacteriophage genomics
06/08/2000CA2353550A1 Small peptides and methods for treatment of asthma and inflammation
06/08/2000CA2353530A1 Antiviral peptides
06/08/2000CA2353524A1 Methods and articles for regenerating living tissue
06/08/2000CA2353521A1 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000CA2353304A1 Polypeptides capable of interacting with the human topoisomerase iii alpha
06/08/2000CA2353108A1 Antisense modulation of cellular inhibitor of apoptosis-2 expression
06/08/2000CA2353107A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2353102A1 Novel tumor antigen protein art-1 and tumor antigen peptide thereof
06/08/2000CA2353090A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
06/08/2000CA2353085A1 Improvement of folliculogenesis
06/08/2000CA2353079A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
06/08/2000CA2352810A1 Spray delivery of cells
06/08/2000CA2352749A1 Anti-dandruff composition comprising an antifungal polypeptide
06/08/2000CA2352555A1 Transport system conjugate
06/08/2000CA2352539A1 Recombinant soluble fc receptors
06/08/2000CA2352538A1 Erythropoietic compounds
06/08/2000CA2352487A1 Utilisation of capsules containing one or more antigenic substances for the prevention and/or treatment of autoimmune diseases
06/08/2000CA2352466A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/08/2000CA2352388A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier
06/08/2000CA2352167A1 Interferon-alpha mediated upregulation of aquaporin expression
06/08/2000CA2352134A1 Pharmaceutical composition comprising an anti-cancer agent and at least a peptide
06/08/2000CA2351731A1 Compositions and methods for regulating bacterial pathogenesis
06/08/2000CA2351671A1 Transgenic circulating endothelial cells
06/08/2000CA2348823A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000CA2348157A1 Methods and compositions for inhibiting neoplastic cell growth
06/08/2000CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2000EP1006197A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells
06/07/2000EP1006194A2 C-erbB-2 external domain: GP75
06/07/2000EP1006188A1 Human chemokines beta10 and beta4 polypeptides and nucleic acids
06/07/2000EP1006187A2 Compositions for the diagnosis, prevention, and treatment of tumor progression
06/07/2000EP1006186A1 Human genes
06/07/2000EP1006185A1 Tissue-specific splice variant of recombination-repair gene rad51b associated with t(12;14)-uterine leiomyomas
06/07/2000EP1006183A1 Recombinant soluble Fc receptors
06/07/2000EP1006182A2 Polypeptide fragments of factor VIIIC, corresponding probes and DNA sequences and DNA constructs
06/07/2000EP1006126A2 Osteogenic peptides
06/07/2000EP1006125A1 Goat epididymal forward motility protein
06/07/2000EP1006124A1 Immunomodulatory and antimicrobial materials, their preparation and use
06/07/2000EP1006122A1 Phenethylamine derivatives
06/07/2000EP1005871A2 Trapped cells and use thereof as a drug
06/07/2000EP1005870A2 Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
06/07/2000EP1005869A1 Bile secretagogues
06/07/2000EP1005868A1 Use of alpha interferon and ribavirin in the manufacture of a medicament for combination therapy for chronic hepatitis C infection
06/07/2000EP1005867A2 Botulinum toxins for modulating cholinergic controlled secretions
06/07/2000EP1005655A2 Method of drug selection
06/07/2000EP1005555A1 Human stress-activated protein kinase, skk4
06/07/2000EP1005552A1 Member of the hematopoietin receptor superfamily
06/07/2000EP1005551A2 Tissue factor pathway inhibitor-3
06/07/2000EP1005550A1 Ubc7-like ubiquitin-conjugating enzyme
06/07/2000EP1005546A2 Compounds for immunotherapy of prostate cancer and methods for their use
06/07/2000EP1005545A1 Human extracellular matrix-1
06/07/2000EP1005544A1 70 human secreted proteins
06/07/2000EP1005543A2 Human herpesvirus - 7 diagnostic and immunologic reagents and uses thereof
06/07/2000EP1005540A1 Ikk-beta proteins, nucleic acids and methods
06/07/2000EP1005539A1 IKK-$g(a) PROTEINS, NUCLEIC ACIDS AND METHODS
06/07/2000EP1005538A1 Gene therapy for alleviating erectile dysfunction
06/07/2000EP1005531A2 Method of treating leukocytes, leukocyte compositions and methods of use thereof
06/07/2000EP1005526A1 Direct expression of peptides into culture media
06/07/2000EP1005494A1 High avidity polyvalent and polyspecific reagents
06/07/2000EP1005492A1 Purification of von willebrand factor by cation exchanger chromatography
06/07/2000EP1005491A1 Modified cytokine receptor protein
06/07/2000EP1005490A1 Zinc free insulin crystals for use in pulmonary compositions
06/07/2000EP1005489A1 Novel polypeptides within the growth factor superfamily
06/07/2000EP1005488A1 Receptor that binds trail
06/07/2000EP1005487A1 The 74 kilodalton outer membrane protein from moraxella catarrhalis
06/07/2000EP1005485A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage
06/07/2000EP1005484A1 Compounds with growth hormone releasing properties
06/07/2000EP1005482A1 Selective induction of cell death by delivery of amino-terminal interleukin-1-alpha pro-piece polypeptide
06/07/2000EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
06/07/2000EP1005376A1 Methods and compositions for use in gene therapy for treatment of hemophilia
06/07/2000EP1005372A1 Anti-cd40l immunotoxins for the treatment of diseases
06/07/2000EP1005366A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof
06/07/2000EP1005361A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY
06/07/2000EP1005360A1 Antioxidant protein 2, gene and methods of use therefor
06/07/2000EP1005359A2 FRACTURE HEALING USING PTHrP ANALOGS
06/07/2000EP1005358A1 Method for preventing and treating hearing loss using a neurturin protein product
06/07/2000EP1005357A1 Peptide antiestrogen compositions and methods for treating breast cancer
06/07/2000EP1005356A1 Novel antibacterial agents
06/07/2000EP1005355A1 Method of treating gastrointestinal ulcers and compositions therefor
06/07/2000EP1005354A1 Peptide mimetics of the cytokine receptor gamma chain
06/07/2000EP1005348A1 Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
06/07/2000EP1005330A1 Methods and compositions for targeting compounds to muscle
06/07/2000EP1005274A1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
06/07/2000EP0983061A4 Methods for administering nutritional indium
06/07/2000EP0950189A4 Brca1 associated protein (bap-1) and uses therefor
06/07/2000EP0812331A4 Mhc-antigen complexes for detecting and purifying antigen-specific t cells
06/07/2000EP0806965A4 Cd44 expression in smooth muscle cells
06/07/2000EP0636171B1 Methods of using antibodies against human chorionic gonadotropin-related determinants to lyse malignant cells
06/07/2000CN1255944A Modified arginine deiminase
06/07/2000CN1255927A Human neuroglia mature factor (GMF) beta homologous gene (CBFBOE11)
06/07/2000CN1255926A 20(S) camptothecin glycoconjugates
06/07/2000CN1255862A Use of avian antibodies
06/07/2000CN1255860A Immunogenic compsns to CCK-b/gastrin-receptor and methods for treatment of tumors
06/07/2000CN1255859A Pharmaceutical antiviral compsn. comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
06/07/2000CN1255858A Cachevia remedy
06/07/2000CN1255857A Histone containing compsn. to treat rheumatoid arthritis
06/07/2000CN1255856A Preventive and therapeutic compsns. for drug induced nephropathy and hepatitis
1 ... 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 ... 3163